Amalgamated Bank Global Blood Therapeutics, Inc. Transaction History

Amalgamated Bank

$12.1 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 09, 2022	BUY	$32.4 - $68.18 $18,759 - $39,476	579 Added 5.87%	10,450 $712,000
Q2 2022 Aug 15, 2022	SELL	$22.3 - $37.39 $5,106 - $8,562	-229 Reduced 2.27%	9,871 $315,000
Q1 2022 Jun 30, 2022	SELL	$25.68 - $35.59 $17,667 - $24,485	-688 Reduced 6.38%	10,100 $350,000
Q4 2021 Feb 15, 2022	BUY	$24.9 - $40.26 $3,535 - $5,716	142 Added 1.33%	10,788 $316,000
Q3 2021 Oct 29, 2021	SELL	$25.48 - $37.34 $16,714 - $24,495	-656 Reduced 5.8%	10,646 $271,000
Q2 2021 Aug 16, 2021	BUY	$32.46 - $43.42 $8,536 - $11,419	263 Added 2.38%	11,302 $396,000
Q1 2021 May 13, 2021	SELL	$38.94 - $50.85 $37,343 - $48,765	-959 Reduced 7.99%	11,039 $450,000
Q4 2020 Feb 12, 2021	BUY	$37.65 - $63.77 $5,948 - $10,075	158 Added 1.33%	11,998 $519,000
Q3 2020 Oct 30, 2020	SELL	$52.76 - $74.49 $15,722 - $22,198	-298 Reduced 2.46%	11,840 $653,000
Q2 2020 Aug 10, 2020	BUY	$48.73 - $81.82 $86,885 - $145,885	1,783 Added 17.22%	12,138 $766,000
Q1 2020 May 13, 2020	SELL	$41.72 - $87.2 $13,976 - $29,212	-335 Reduced 3.13%	10,355 $529,000
Q4 2019 Feb 13, 2020	BUY	$45.7 - $81.86 $47,299 - $84,725	1,035 Added 10.72%	10,690 $850,000
Q3 2019 Nov 13, 2019	SELL	$45.35 - $57.91 $5,305 - $6,775	-117 Reduced 1.2%	9,655 $468,000
Q2 2019 Aug 14, 2019	BUY	$52.6 - $63.29 $94,890 - $114,175	1,804 Added 22.64%	9,772 $514,000
Q1 2019 May 15, 2019	BUY	$39.99 - $53.48 $25,913 - $34,655	648 Added 8.85%	7,968 $422,000
Q4 2018 Feb 15, 2019	BUY	$31.54 - $46.67 $230,872 - $341,624	7,320 New	7,320 $300,000
Q3 2018 Nov 14, 2018	SELL	$38.0 - $51.1 $289,712 - $389,586	-7,624 Closed	0 $0
Q2 2018 Jul 18, 2018	BUY	$38.7 - $50.15 $93,654 - $121,363	2,420 Added 46.5%	7,624 $345,000
Q1 2018 May 22, 2018	BUY	$39.6 - $65.9 $206,078 - $342,943	5,204 New	5,204 $251,000

Others Institutions Holding GBT

# of Institutions

Shares Held

288K

Call Options Held

Put Options Held

View Full List

About Global Blood Therapeutics, Inc.

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

More about GBT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

News

Stay updated on Amalgamated Bank with notifications on news.

Account